Abilify and Sweating - excessive - a phase IV clinical study of FDA data

Summary:

Sweating - excessive is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cymbalta, and have Schizophrenia.

The phase IV clinical study analyzes which people have Sweating - excessive when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,443 Abilify users. Check the latest studies of Abilify.

What is Sweating - excessive?

Sweating - excessive is found to be associated with 3,409 drugs and 3,601 conditions by eHealthMe. Check the latest studies of Sweating - excessive.

On Nov, 21, 2025

97,308 people reported to have side effects when taking Abilify.
Among them, 1,063 people (1.09%) have Sweating - excessive.

Could Abilify cause Sweating - excessive?

Among these 1,063 people:

How long have people been on Abilify when they have Sweating - excessive? *

Click here to view more results

What is the gender of people who have Sweating - excessive when taking Abilify? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Sweating - excessive?

- Check whether Sweating - excessive is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,443 reports)

Sweating - excessive treatments and more:

Sweating - excessive (147,206 reports)

How severe was Sweating - excessive and when was it recovered:

Sweating - excessive in Abilify

Expand to all the drugs that have ingredients of aripiprazole:

Sweating - excessive and drugs with ingredients of aripiprazole (1,525 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Abilify side effects:

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Sweating - excessive:

Browse all the drugs that are associated with Sweating - excessive:

Sweating - excessive (3,409 drugs)

Common conditions associated with Sweating - excessive:

Depression: 9,010 reports
Pain exacerbated: 8,296 reports
Pain relief: 8,279 reports
High blood pressure: 6,490 reports
Ra: 6,337 reports
Acupuncture and pain: 5,598 reports
Multiple sclerosis: 4,898 reports
Anxiety: 4,633 reports
Diabetes - type 2: 3,974 reports
High blood cholesterol and triglycerides: 3,494 reports

Browse all the conditions that are associated with Sweating - excessive:

Sweating - excessive (3,601 conditions)

Drugs similar to Abilify and Sweating - excessive :

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.